Dista-Myo2 Natural history of distal and myofibrillar myopathies
Research type
Research Study
Full title
Dista-Myo2: Natural history of distal and myofibrillar myopathies assessed by clinical and technological outcome measures.
IRAS ID
355211
Contact name
Giorgio Tasca
Contact email
Sponsor organisation
Newcastle University
Duration of Study in the UK
2 years, 2 months, 7 days
Research summary
Dista-Myo2 is an international research study aiming to improve how we assess muscle weakness and walking difficulties in people with rare muscle conditions known as Distal Myopathies (DM) and Myofibrillar Myopathies (MFM). These diseases often affect the hands, feet, and lower limbs, leading to loss of independence and reduced quality of life.
Currently, standard clinical methods do not fully capture how these diseases progress, especially in those more severely affected. This study is exploring new ways to identify and monitor disease progression using advanced measurement techniques. These include functional assessments, dexterity tests and MyoTools, which measure strength in the arms and legs, and in-shoe sensors, which record how a person walks in real time.
By undertaking these assessments, we aim to gain a clearer understanding of how muscle weakness and mobility change over time in people with DM and MFM. The goal is to see whether these assessments provide meaningful insights into disease progression, which could improve how we track changes and evaluate the impact of future treatments.
Participants will be adults diagnosed with DM or MFM. In Newcastle, up to 35 participants will be recruited from the John Walton Muscular Dystrophy Research Centre (JWMDRC) database. Recruitment will start with 20 participants, with the potential to include additional participants if possible. Those who previously took part in the original Dista-Myo study will be invited to continue for an additional 12 to 24 months. New participants will attend two study visits 12 months apart. Each visit includes walking tests, muscle strength assessments, and questionnaires about daily activities and quality of life.
Data from the study will be analysed using statistical methods to examine changes in muscle strength, mobility, and daily function over time, allowing us to understand disease progression and the usefulness of these new assessment tools.
Findings from this research could lead to better ways of monitoring these conditions and support the development and evaluation of future therapies.REC name
East Midlands - Nottingham 1 Research Ethics Committee
REC reference
25/EM/0275
Date of REC Opinion
28 Nov 2025
REC opinion
Favourable Opinion